Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone
暂无分享,去创建一个
[1] R. Jilka,et al. Sex steroids and bone. , 2002, Recent progress in hormone research.
[2] David Handelsman,et al. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. , 2001, The Journal of clinical endocrinology and metabolism.
[3] A. Vermeulen. Androgen replacement therapy in the aging male--a critical evaluation. , 2001, The Journal of clinical endocrinology and metabolism.
[4] H. Ke,et al. Lasofoxifene (CP‐336,156) Protects Against the Age‐Related Changes in Bone Mass, Bone Strength, and Total Serum Cholesterol in Intact Aged Male Rats , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] K. Toda,et al. Sex- and age-related response to aromatase deficiency in bone. , 2001, Biochemical and biophysical research communications.
[6] R. Eastell,et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. , 2000, The Journal of clinical investigation.
[7] G. Iwamoto,et al. Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .
[8] A. Thorburn,et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Boonen,et al. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. , 2000, Bone.
[10] H. Frost,et al. Making Rats Rise to Erect Bipedal Stance for Feeding Partially Prevented Orchidectomy‐Induced Bone Loss and Added Bone to Intact Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] J. Gustafsson,et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Thompson,et al. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat. , 2000, Endocrinology.
[13] Arndt F Schilling,et al. Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.
[14] S. Boonen,et al. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement , 1999, Endocrinology.
[15] J. Berlin,et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. , 1999, The Journal of clinical endocrinology and metabolism.
[16] J. Berlin,et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. , 1999, The Journal of clinical endocrinology and metabolism.
[17] S. Boonen,et al. Action of androgens versus estrogens in male skeletal homeostasis. , 1998, Bone.
[18] E. Simpson. Genetic mutations resulting in estrogen insufficiency in the male , 1998, Molecular and Cellular Endocrinology.
[19] B. L. Riggs,et al. A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] G. Verbeke,et al. Factors Associated with Cortical and Trabecular Bone Loss as Quantified by Peripheral Computed Tomography (pQCT) at the Ultradistal Radius in Aging Women , 1997, Calcified Tissue International.
[21] D. Vanderschueren,et al. Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. , 1994, Bone and mineral.
[22] J. S. Tenover,et al. Effects of testosterone supplementation in the aging male. , 1992, The Journal of clinical endocrinology and metabolism.
[23] D. Vanderschueren,et al. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. , 1992, Endocrinology.
[24] R. Turner,et al. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] J. Verhaeghe,et al. Bone and Mineral Metabolism in BB Rats With Long-Term Diabetes: Decreased Bone Turnover and Osteoporosis , 1990, Diabetes.
[26] J. Verhaeghe,et al. Osteocalcin during the reproductive cycle in normal and diabetic rats. , 1989, The Journal of endocrinology.
[27] Frost Hm,et al. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987 .
[28] H. Frost,et al. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987, Bone and mineral.
[29] A. Vermeulen,et al. Radioimmunoassay of 17β-hydroxy-5α-androstan-3-one, 4-androstene-3,17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone and progesterone and its application to human male plasma , 1976 .